Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Wellcome Trust
Wellcome Trust
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
KBI Biopharma extends contract with a big pharma giant after a successful FDA inspection
The contract has been renewed and extended until at least 2029, and will now include the purchase of two therapeutic products
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
New FAIRY viral assay could 'revolutionise' the response to future pandemics
The assay, which can detect the infectiousness of a virus in a matter of minutes, offers a quicker and cheaper alternative to the standard cell culture approach
New advice from BOLA and Labtex on cleaning and handling of PTFE products after use
The companies share: "Abrasive scouring agents may result in a milkiness of the vessels made of PFA and FEP. You may use all neutral detergents (pH 7). For higher contamination...
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Research & Development
Oxford clinical trial for COVID-19 treatments expands internationally
The international trial will initially focus on the treatments aspirin and colchicine, since these are readily available and affordable
Research & Development
Study demonstrates way to target hard-to-treat cancer mutation
The study was funded by Cancer Research UK and Wellcome
Research & Development
Collaborators use CRISPR to catch cancer-causing gene fusions
A team from the Wellcome Sanger Institute and collaborators have identified a new gene fusion that presents a novel drug target for multiple cancers, including brain and ovarian
Finance
Karuna completes $42 million financing round
Participants include ARCH Venture Partners, Wellcome Trust, PureTech Health, Steven Paul MD, and other undisclosed investors
Hi Tech Manufacturing
£10m research competition to tackle antimicrobial resistance
Move aims to encourage the development of innovative scientific approaches to addressing antimicrobial resistance
Regulatory
Karuna receives $8m Wellcome Trust award
The funding will be used to advance the company's lead product candidate, KarXT, through a Phase II study in people with schizophrenia
Research & Development
Polyphor and Wellcome Trust to develop novel antibiotics against multi-drug resistant Gram-negative pathogens
Final milestone reached ahead of schedule triggering payment of a CHF 0.97 million convertible loan amount
Subscribe now